Clinical Trial Update: Global Study of Del-desiran for the Treatment of DM1 [Phase 3]

View source ↗

Summary

Phase 3 global trial of Del-desiran for Myotonic Dystrophy Type 1 (DM1) is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• Del-desiran (del-desiran)

Snippet

Sponsor: Avidity Biosciences, Inc. | Conditions: DM1, Myotonic Dystrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING